CIVITTA attracted Horizon 2020 grant for BIOsens

CIVITTA Ukraine attracted funds for Ukranian-based biotechnology start-up, BIOsens, through Horizon 2020 SME Instrument Phase 1.

BIOsens develops a device which conducts automated on-site highly accurate rapid crops analysis, and further saves and delivers the results using the blockchain. Architectural breakthrough allows BIOsens to reach the accuracy of laboratory testing and the speed of on-site rapid strips.

CIVITTA helps start-ups to win Horizon 2020 SME Instruments

Horizon 2020 SME Instrument is an opportunity for innovative SMEs to bring their ideas to the market. Through this program, startups can attract from 50 k EUR in Phase 1 up to 2.5 mn EUR (max for Phase 2) of equity free funding, which can be further spent on preparation for rapid commercialization of their solutions. With a total of 11 Ukrainian companies funded though SME Instrument, CIVITTA team helped 8 winners to prepare successful proposals. 

Phase 1 funding will allow BIOsens to validate and elaborate its commercialization strategy. In particular, the startup will use this money to conduct market research and validate its market entry strategy and value proposition, analyse regulatory requirements and develop Intellectual Property Rights (IPR) protection strategy, and elaborate its business model and business plan.

“BIOsens aims for global commercialization with a mission to provide safe food to all people over the world. We believe that funds attracted through Horizon 2020 SME Instrument will help us in achieving this aim. We are thankful to CIVITTA for helping us in this journey and think that more Ukrainian startups should apply for this grant as well.” - Andrii Karpiuk, CEO of BIOsens

What support is available and how can we help you?

SME instrument supports close-to-market activities, with the aim to give a strong boost to breakthrough innovation with a market-creating potential. Highly innovative SMEs with a clear commercial ambition and a potential for high growth and internationalization are the prime target.

If an innovative startup wants to attract funds to commercialize its solution, SME instrument is a great opportunity to get equity free funding.

By having experience in a significant number of successful applications, CIVITTA has developed expertise and is a reliable partner for funding attraction.